Sun Pharmaceutical scrip dips 3 pc after Q3 results

Shares of drug major Sun Pharmaceutical Industries today fell nearly 3 per cent after the company reported 75 per cent dip in its consolidated net profit for the third quarter ended December 2017.
The stock dipped 2.80 per cent to settle at Rs 572.65 on NSE. During the day, it touched a high of Rs 591.80 and a low of Rs 571.20.
On BSE, shares of the company ended the day at Rs 574.45, down 2.53 per cent from the previous close. The stock had touched a high of Rs 593.90 and a low of Rs 570 in intra-day trade.

On the equity volume front, 66.30 lakh shares of the firm were traded on NSE while 7.28 lakh scrips changed hands on BSE.
Sun Pharmaceutical Industries today reported 75.17 per cent dip in its consolidated net profit at Rs 365.39 crore for the third quarter ended December 31, 2017-18.
The drug major had reported a net profit of Rs 1,471.82 crore in the October-December quarter of 2016-17.
Its total revenue from operations stood at Rs 6,653.23 crore during the third quarter of 2017-18. It was Rs 7,925.11 crore during the same period of the previous fiscal.